Preablative Stimulated Thyroglobulin and Thyroglobulin Reduction Index as Decision-Making Markers for Second Radioactive Iodine Therapy in Patients with Structural Incomplete Response.
Lihua WangCanhua YunFengyan HuangJuan XiaoYanli JuFang ChengWei ZhangHongying JiaPublished in: Cancer management and research (2021)
DTC patients with SIR could benefit through second RAI treatment. PresTg before each RAI therapy and TRI could be considered as effective decision-making markers for second RAI therapy and as predictive indications for clinical outcomes.